CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
A Phase II Study to Evaluate the Efficacy of Ramosetron, Aprepitant, and Dexamethasone in Preventing Cisplatin-Induced Nausea and Vomiting in Chemotherapy-Naive Cancer Patients
Geundoo Jang, Hun Ho Song, Keon Uk Park, Hyeong Su Kim, Dae Ro Choi, Jung Hye Kwon, Ho Young Kim, Boram Han, Jung Han Kim, Joo Young Jung, Hyo Jung Kim, Dae Young Zang
Cancer Research and Treatment. 2013;45(3):172-177.   Published online 2013 September 30    DOI: https://doi.org/10.4143/crt.2013.45.3.172

Excel Download

A Phase II Study to Evaluate the Efficacy of Ramosetron, Aprepitant, and Dexamethasone in Preventing Cisplatin-Induced Nausea and Vomiting in Chemotherapy-Naive Cancer Patients
Cancer Research and Treatment. 2013;45(3):172-177   Crossref logo
Link1 Link2

Editorial Comment to Palonosetron with aprepitant plus dexamethasone to prevent chemotherapy-induced nausea and vomiting during gemcitabine/cisplatin in urothelial cancer patients
International Journal of Urology. 2015;22(10):915-915   Crossref logo
Link1 Link2

Palonostron with Aprepitant–Dexamethasone to Prevent Chemotherapy-Induced Nausea and Vomiting During Gemcitabine/Cisplatin in Urothelial Cancer Patients
Annals of Oncology. 2012;23:xi142   Crossref logo
Link1 Link2

Safety and efficacy of aprepitant for chemotherapy-induced nausea and vomiting in pediatric patients: A prospective, observational study
Pediatric Blood & Cancer. 2013;61(6):1111-1113   Crossref logo
Link1 Link2

Efficacy and safety of triple therapy with aprepitant, palonosetron, and dexamethasone for preventing nausea and vomiting induced by cisplatin-based chemotherapy for gynecological cancer: KCOG-G1003 phase II trial
Supportive Care in Cancer. 2014;22(11):2891-2898   Crossref logo
Link1 Link2 Link3

Aprepitant, Granisetron and Dexamethasone Versus Palonosetron and Dexamethasone for Cisplatin-Induced Nausea and Vomiting in Patients with Upper Gastrointestinal Cancer: a Randomized Crossover Phase Ii Trial (Kdog 1002)
Annals of Oncology. 2014;25:iv521   Crossref logo
Link1 Link2 Link3

A randomized phase II study of aprepitant, ondansetron and dexamethasone for chemotherapy-induced nausea and vomiting in Chinese breast cancer patients receiving moderately emetogenic chemotherapy
European Journal of Cancer Supplements. 2008;6(7):198   Crossref logo
Link1 Link2

3079 POSTER 3-day Aprepitant Plus Palonosetron and Dexamethasone for the Prevention of Chemotherapy-induced Nausea and Vomiting in Patients Receiving Cisplatin-based Chemotherapy
European Journal of Cancer. 2011;47:S245   Crossref logo
Link1 Link2

Efficacy and safety of olanzapine combined with aprepitant, palonosetron, and dexamethasone for preventing nausea and vomiting induced by cisplatin-based chemotherapy in gynecological cancer: KCOG-G1301 phase II trial
Supportive Care in Cancer. 2015;24(2):675-682   Crossref logo
Link1 Link2 Link3

Phase II study of palonosetron, aprepitant and dexamethasone to prevent nausea and vomiting induced by multiple-day emetogenic chemotherapy
Supportive Care in Cancer. 2017;   Crossref logo
Link1 Link2 Link3

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.